W
WAVEMAN · COMPANY
SHC · Sotera Health Co
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

SHC

Sotera Health Co
HEALTHCARE SERVICES · SERVICES-MISC HEALTH & ALLIED SERVICES, NEC · CIK 0001822479
FORM 144 · 2☆ WATCH
INSIDER NET · 180D
-$796.8M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
226
13F, latest reported quarter
REVENUE GROWTH
+5.7%
XBRL, annual
NET MARGIN
6.7%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$796.8M over 180 days
-$24.0M over 90 days · -$772.8M of it by a 10%+ holder
below 98% of Healthcare Services
CONGRESS
no member of Congress has reported trading it
FUNDS
226 funds added or opened last quarter
more than 82% of Healthcare Services
REVENUE
+5.7% year over year
below 64% of Healthcare Services
MARGIN
6.7% net margin
more than 75% of Healthcare Services
BUYBACKS
no share repurchases reported
SHORT
no short interest reported
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$796.8M across 5 people in 180 days.
226 funds added or opened positions in the latest 13F quarter, of 322 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +17.3%
+17.3%12M
-19%-5%+8%+21%2025-092025-102025-122026-032026-052026-072026-09 2026-05-13 · Warburg Pincus (Cayman) XI, L.P. sold $289.8M2026-05-13 · Warburg Pincus XI, L.P. sold $289.8M2025-11-10 · Warburg Pincus Private Equity XI-C, L.P. sold $281.7M2025-11-10 · Warburg Pincus Partners II, L.P. sold $281.7M2026-03-06 · Warburg Pincus Partners GP LLC sold $229.1M2026-03-06 · Warburg Pincus Partners II, L.P. sold $229.1M2026-05-13 · GTCR FUND XI/C LP sold $193.2M2025-11-10 · GTCR FUND XI/A LP sold $187.8M2025-09-05 · Warburg Pincus XI-C, LLC sold $181.3M2025-09-05 · WARBURG PINCUS & CO. sold $181.3M2025-12-03 · WARBURG PINCUS LLC sold $158.7M2025-12-03 · Warburg Pincus Partners GP LLC sold $158.7M2026-03-06 · GTCR CO-INVEST XI LP sold $152.7M2025-09-05 · GTCR INVESTMENT XI LLC sold $120.9M2025-12-03 · GTCR FUND XI/A LP sold $105.8M2026-08-17 · Petras Michael B. Jr. sold $15.7M2025-12-08 · Petras Michael B. Jr. sold $6.5M2026-08-17 · Petras Michael B. Jr. sold $5.4M2025-12-08 · Petras Michael B. Jr. sold $5.2M2026-08-07 · Rutz Michael P sold $2.8M2025-12-08 · Petras Michael B. Jr. sold $645.5K2026-08-17 · Michael B. Petras, Jr. filed to sell $21.6M2026-08-07 · Rutz Michael P filed to sell $2.8M
INSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $796.8M sold by insiders over 180 days, 226 funds added last quarter, $24.5M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
NTRACSTLPGNYHIMSWGSPRVATDOCAVAHGHADUSSERABDSX
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Sotera Health Co insiders sold a net $796.8M of stock across 32 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Petras Michael B. Jr.
Executive Chairman
SELL
2026-08-17
294,515.0
$5.4M
Petras Michael B. Jr.
Executive Chairman
SELL
2026-08-17
850,000.0
$15.7M
Rutz Michael P
President of Sterigenics
SELL
2026-08-07
150,000.0
$2.8M
Warburg Pincus (Cayman) XI, L.P.
Director
SELL
2026-05-13
19,102,952.0
$289.8M
Warburg Pincus XI, L.P.
Director
SELL
2026-05-13
19,102,952.0
$289.8M
32 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 27 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Sessa Capital IM, L.P.
27,050,000.0 sh
$480.1M
Darsana Capital Partners LP
27,000,000.0 sh
$479.2M
BlackRock, Inc.
24,148,424.0 sh
$428.6M
Sculptor Capital LP
24,000,000.0 sh
$426.0M
Sachem Head Capital Management LP
15,560,000.0 sh
$276.2M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
Michael B. Petras, Jr.
FILED 2026-08-17
$21.6M
Rutz Michael P
FILED 2026-08-07
$2.8M
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
MIG Core ETF
$16.1M POSITION · AS OF 2026-02-28
3.0%
Global Endurance Portfolio
$333.9K POSITION · AS OF 2026-03-31
2.2%
Janus Henderson Contrarian Fund
$69.6M POSITION · AS OF 2026-03-31
1.6%
NexPoint Event Driven Fund
$1.1M POSITION · AS OF 2026-03-31
1.4%
Brandes U.S. Small-Mid Cap Value ETF
$1.5M POSITION · AS OF 2026-03-31
1.0%
Research Affiliates Deletions ETF
$228.2K POSITION · AS OF 2026-03-31
0.7%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Executive pay vs shareholder return · Michael B. Petras, Jr
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2023
$9.7M
$31.2M
$1.4M
-33%
+32%
2022
$16.7M
$5.9M
$2.0M
-67%
+30%
2021
$2.2M
-$2.4M
$658.9K
-6%
+32%
2020
$17.2M
$22.4M
$5.0M
+9%
+5%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$1.2B$1.1B$1.0B$1.0B
GROSS PROFIT$645.5M$602.3M$577.2M$557.0M
OPERATING INCOME—$297.6M$276.7M$248.3M
NET INCOME$77.9M$44.4M$51.4M$-233.6M
EPS (DILUTED)0.270.160.18-0.83
OPERATING CASH FLOW$287.2M$224.2M$-147.7M$278.0M
CASH$344.6M$277.2M$296.4M$395.2M
LONG-TERM DEBT$2.1B$2.2B$2.2B$1.7B
BUYBACKS———$0
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →